Châu Âu triển khai chương trình tiêm chủng mở rộng vắcxin phòng bệnh

Trong bối cảnh số ca mắc mới và tử vong do đại dịch COVID-19 không ngừng tăng khiến nhiều nước phải siết chặt các biện pháp hạn chế để khống chế, Liên minh châu Âu (EU) tuyên bố sẽ triển khai chiến dịch tiêm đại trà vắcxin phòng ngừa trước cuối năm nay.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh